Insulin Glargine U-300 00955-3900-03
Generic: Insulin Glargine
- Manufacturer
- Sanofi-Aventis U.s. Llc
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- April 1, 2023
- Listing Expires
- December 31, 2026
- Application
- BLA206538
Need to source Insulin Glargine U-300? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Insulin Glargine | 300 [iU]/mL |
Drug Class
Insulin Analog [EPC]Insulin Analog [EPC]Insulin [CS]
Selected Package
00955-3900-03Selected3 SYRINGE in 1 CARTON (0955-3900-03) / 1.5 mL in 1 SYRINGE (0955-3900-01)